A Granulomatous Drug Eruption Induced by Entecavir

A Granulomatous Drug Eruption Induced by Entecavir

Entecavir (Baraclude®, Bristol-Myers Squibb) is a potent and selective antiviral agent that has demonstrated efficacy in patients with chronic hepatitis B. The most frequent adverse events attributed to entecavir include increased alanine aminotransferase, upper respiratory tract infection, headache, abdominal pain, cough, pyrexia, fatigue, and diarrhea. Although quite a few randomized double-b...

Granulomatous drug eruption associated with imipramine

GA: granuloma annulare IGDR: interstitial granulomatous drug reaction INTRODUCTION Granulomatous drug eruptions are rare and include interstitial granulomatous drug reaction, drug-induced granuloma annulare, drug-induced accelerated rheumatoid nodulosis, and druginduced sarcoidosis. The differential diagnosis is broad and includes granuloma annulare, lichen planus, connective tissue disease, sa...

Fixed Drug Eruption Induced by Levocetirizine

[Lichenoid drug eruption induced by olanzapine].

Lichenoid drug eruptions can mimic idiopathic lichen planus and other dermatoses. The list of drugs that can cause them is long and growing steadily. Although cutaneous side effects of antipsychotics are rare, various cutaneous manifestations have been reported in association with olanzapine. We present the case of a patient who developed an atypical lichenoid eruption due to olanzapine. A revi...

Fixed drug eruption induced by atenolol

Fixed drug eruption (FDE) is characterized by recurrent well-defined lesions in the same location each time the responsible drug is taken. We report here a case of multiple FDE induced by atenolol in a 48-year-old woman confirmed by positive patch test in previously affected sites. Beta-blockers-induced FDE are very rare. Only two cases had been reported in the literature. To the best of our kn...